SCHEMBL12836268

SCHEMBL12836268

CN1CCN(C2CCc3cccnc32)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 10/20 0.46
CYP2D6 P10635 2/20 0.41
DRD2 P14416 1/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
DRD1 P21728 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR7 P34969 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8955169 0.87 CHRNA7 (0.42) CXCR4HTR2AHTR2CHTR2BFNTA
SCHEMBL9963450 0.85 CXCR4 (0.46) CXCR4CYP2D6HRH1
SCHEMBL9934555 0.83 FNTA (0.53) CXCR4CYP2D6CHRM2CHRM1HTR2A
SCHEMBL9933651 0.83 FNTA (0.53) CXCR4CYP2D6CHRM2CHRM1HTR2A
SCHEMBL9933633 0.81 FNTA (0.45) FNTAFNTB
SCHEMBL9673260 0.79 CXCR4 (0.46) CXCR4CYP2D6
SCHEMBL9672362 0.78 CXCR4 (0.46) CXCR4CYP2D6TSHR
SCHEMBL9742041 0.78 CHRNA7 (0.44) CXCR4TSHRFNTAFNTB
SCHEMBL5871397 0.77 HTR2A (0.46) DRD2HTR1AADRA2CDRD1HTR2A
SCHEMBL9934271 0.77 FNTA (0.58) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470021-B1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME (US) 2014-10-22 EP disclosed
WO-2011025690-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2011-03-03 WO disclosed